We’ve put together this list of 5-letter words starting with REPL to help you figure out today’s answer, if the word is more difficult or there are so many options that you’re overwhelmed with choices ...

Replimune Group Inc. stocks have been trading down by -18.66 percent following negative sentiment around its latest clinical trial outlook. Live Update At 08:34:16 EDT: On Tuesday, July 28, 2026 ...

Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...

Replimune Group Inc. stocks have been trading down by -14.69 percent following negative sentiment over its latest clinical trial update. The FDA issued a Complete Response Letter rejecting Replimune’s ...

This project is a proof-of-concept that runs a JavaScript engine inside a web browser by compiling it to WebAssembly. The engine is Goja — a pure-Go implementation of ECMAScript 5.1 — and the ...

Replimune Group Inc. stocks have been trading down by -12.28 percent following negative sentiment around its latest clinical trial developments. The FDA issued a Complete Response Letter rejecting ...

FDA has now rejected Replimune’s melanoma immunotherapy RP1 on two separate occasions The drug was under consideration for use with Bristol Myers Squibb’s (BMY) Opdivo therapy Regulators maintained ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...

Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...